Brilinta 90 mg Tablet - Strip of 180

Prescription Required

Compositions : Ticagrelor 90.0mg

₹4,209.68 (Incl. GST)

MRP :

Out of stock

Delivery within 2 to 7 Working Days

Manufacture/Marketer: AstraZeneca India

Brilinta 90 mg Tablet is a prescription medication primarily used for the prevention of cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (heart attack). The active ingredient in Brilinta is ticagrelor, which belongs to a class of drugs known as antiplatelet agents. These medications work by inhibiting platelet aggregation, thereby reducing the risk of blood clots that can lead to serious cardiovascular complications. Each Brilinta 90 mg Tablet contains 90 mg of ticagrelor, along with various inactive ingredients that aid in the formulation and absorption of the drug. The primary therapeutic purpose of Brilinta is to lower the incidence of heart attacks and strokes in at-risk patients by preventing the formation of blood clots. It is essential for patients to understand that Brilinta is not a substitute for aspirin but is often used in conjunction with it to enhance its antiplatelet effects. The medication is typically prescribed following an acute coronary event or in patients with a history of significant cardiovascular disease, making it a critical component of secondary prevention strategies in cardiology. Brilinta is taken orally, and adherence to the prescribed dosage and regimen is crucial for maximizing its therapeutic benefits while minimizing potential risks. As with any medication, it is important for patients to discuss their complete medical history and any other medications they are taking with their healthcare provider to ensure safe and effective use of Brilinta 90 mg Tablet.

Uses & Benefits

  • Reduces the risk of heart attack and stroke in patients with acute coronary syndrome.
  • Helps prevent blood clots in patients with a history of myocardial infarction.
  • Enhances the effectiveness of aspirin when used in combination therapy.
  • Improves overall cardiovascular outcomes in high-risk patients.
  • May be used in patients undergoing percutaneous coronary intervention (PCI).
  • Supports long-term management of patients with established cardiovascular disease.
  • Can be beneficial in reducing the incidence of stent thrombosis after coronary stenting.
How Brilinta 90 mg Tablet works

  • Ticagrelor, the active ingredient in Brilinta 90 mg Tablet, works by inhibiting the P2Y12 receptor on platelets.
  • This inhibition prevents platelet activation and aggregation, reducing the likelihood of clot formation.
  • Brilinta has a rapid onset of action, providing immediate antiplatelet effects.
  • The drug's effects are reversible, allowing for better management of bleeding risks compared to some other antiplatelet agents.
  • Brilinta also enhances the effects of aspirin, making it more effective when used together.
How to use Brilinta 90 mg Tablet

  • Take Brilinta 90 mg Tablet orally, with or without food.
  • The usual recommended dose is one tablet (90 mg) twice daily.
  • It is important to take the medication at the same times each day to maintain consistent blood levels.
  • Do not crush or chew the tablet; swallow it whole with water.
  • Continue taking Brilinta as prescribed by your healthcare provider, even if you feel well.
  • If you miss a dose, take it as soon as you remember unless it's almost time for your next dose; do not double up on doses.
  • Consult your doctor regarding the duration of treatment based on your individual health needs.
Lifestyle Advice

  • Maintain a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Avoid smoking and limit alcohol consumption to reduce cardiovascular risks.
  • Monitor your blood pressure and cholesterol levels regularly.
  • Stay hydrated and manage stress through relaxation techniques or counseling.
  • Adhere to regular follow-up appointments with your healthcare provider to assess your treatment plan.

Side Effects

  • Common side effects may include:
    • Bleeding or bruising more easily than normal.
    • Headache or dizziness.
    • Nausea or diarrhea.
  • Serious side effects that require immediate medical attention include:
    • Signs of severe bleeding such as unusual bruising, blood in urine or stools, or coughing up blood.
    • Shortness of breath or chest pain.
    • Severe allergic reactions including rash, itching, or swelling.

Precautions and Warnings

  • Do not use Brilinta if you have active bleeding disorders or a history of intracranial hemorrhage.
  • Inform your doctor about any other medications you are taking to avoid potential interactions.
  • Avoid alcohol while taking this medication due to increased bleeding risk.
  • Use caution when driving or operating machinery until you know how Brilinta affects you.
  • Pregnant or breastfeeding women should consult their healthcare provider before using this medication.
  • Patients with liver or kidney impairment should use Brilinta cautiously and under medical supervision.
1. What should I do if I miss a dose of Brilinta 90 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not take two doses at once.

2. Can I take Brilinta if I am pregnant?
Brilinta should be used during pregnancy only if clearly needed. Consult your healthcare provider for advice.

3. Are there any foods I should avoid while taking Brilinta?
There are no specific food interactions; however, maintain a balanced diet and consult your doctor for personalized advice.

4. What are the common side effects of Brilinta?
Common side effects include bleeding, bruising, headache, and dizziness. Contact your doctor if these persist or worsen.

5. Can I drink alcohol while taking Brilinta?
Limit alcohol consumption as it may increase the risk of bleeding. Discuss with your healthcare provider.

6. How should I store Brilinta?
Store Brilinta at room temperature away from moisture and heat. Keep out of reach of children.

7. Who should avoid taking Brilinta?
Patients with active bleeding disorders or those who have had a recent major surgery should avoid Brilinta. Consult your doctor.

No content available for this section.

SKU E626
Country of Manufacture India
Manufacturer Address AstraZeneca India
Return/Buy Back policy Non-returnable
Prescription Required Yes
Seller Kogland Commerce Pvt Ltd (TN)

Door Step Delivery

Quick and Secure

No Hidden Charges

Pay only what's shown

18K Pincodes Served

With Trust & Reliability

Customer Reviews

No reviews yet

Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.

Write Your Own Review

Only registered users can write reviews. Please Sign in or create an account

Please wait…

Share Your Requirements With Us

Please fill out the form below. We'll get back to you. Thank you for your patience.